This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House
Inovio Pharmaceuticals Inc
INO : NYSE : Health Care
$10.04 -0.18 | -1.76%
Today's Range: 10.01 - 10.39
Avg. Daily Volume: 1,509,000
09/22/14 - 2:35 PM ET

PEER GROUP: Biotechnology



Ticker Company Name Recent
Price($)
Market
Cap($M)
Price/
Earnings
Net Sales
TTM($M)
Net Income
TTM($M)
INO INOVIO PHARMACEUTICALS INC 10.22 617.28 n/m 17.39 310.91
LXRX LEXICON PHARMACEUTICALS INC 1.46 751.64 n/m 2.60 123.45
ENTA ENANTA PHARMACEUTICALS INC 39.92 741.83 22.43 46.45 1532.79
NLNK NEWLINK GENETICS CORP 26.11 728.70 n/m 1.11 -4.75
RPTP RAPTOR PHARMACEUTICAL CORP 10.77 675.74 n/m 45.30 215604.76
PRTA PROTHENA CORP PLC 22.90 626.91 n/m 47.69 5123.76
MNTA MOMENTA PHARMACEUTICALS INC 11.60 612.63 n/m 45.24 51.82
OREX OREXIGEN THERAPEUTICS INC 4.89 599.20 n/m 3.43 0.00
ONVO ORGANOVO HOLDINGS INC 6.99 548.58 n/m 0.37 -68.56
OMED ONCOMED PHARMACEUTICALS 18.00 535.70 n/m 43.95 113.98
HPTX HYPERION THERAPEUTICS INC 25.99 535.34 28.88 90.69 1021.32
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

INO Ind Avg S&P 500
n/m 82.53 19.94
 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades


Top Rated Stocks Top Rated Funds Top Rated ETFs